Literature DB >> 26325556

Improving Patient Outcomes With Cancer Genomics: Unique Opportunities and Challenges in Pediatric Oncology.

Robert W Schnepp1, Kristopher R Bosse1, John M Maris1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26325556      PMCID： PMC4599710          DOI： 10.1001/jama.2015.9794

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  13 in total

1.  Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.

Authors:  Maurizio Aricò; Martin Schrappe; Stephen P Hunger; William L Carroll; Valentino Conter; Stefania Galimberti; Atsushi Manabe; Vaskar Saha; André Baruchel; Kim Vettenranta; Keizo Horibe; Yves Benoit; Rob Pieters; Gabriele Escherich; Lewis B Silverman; Ching-Hon Pui; Maria Grazia Valsecchi
Journal:  J Clin Oncol       Date:  2010-09-27       Impact factor: 44.544

2.  Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma.

Authors:  F G Barr; N Galili; J Holick; J A Biegel; G Rovera; B S Emanuel
Journal:  Nat Genet       Date:  1993-02       Impact factor: 38.330

3.  Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.

Authors:  Thomas F Eleveld; Derek A Oldridge; Virginie Bernard; Jan Koster; Léo Colmet Daage; Sharon J Diskin; Linda Schild; Nadia Bessoltane Bentahar; Angela Bellini; Mathieu Chicard; Eve Lapouble; Valérie Combaret; Patricia Legoix-Né; Jean Michon; Trevor J Pugh; Lori S Hart; JulieAnn Rader; Edward F Attiyeh; Jun S Wei; Shile Zhang; Arlene Naranjo; Julie M Gastier-Foster; Michael D Hogarty; Shahab Asgharzadeh; Malcolm A Smith; Jaime M Guidry Auvil; Thomas B K Watkins; Danny A Zwijnenburg; Marli E Ebus; Peter van Sluis; Anne Hakkert; Esther van Wezel; C Ellen van der Schoot; Ellen M Westerhout; Johannes H Schulte; Godelieve A Tytgat; M Emmy M Dolman; Isabelle Janoueix-Lerosey; Daniela S Gerhard; Huib N Caron; Olivier Delattre; Javed Khan; Rogier Versteeg; Gudrun Schleiermacher; Jan J Molenaar; John M Maris
Journal:  Nat Genet       Date:  2015-06-29       Impact factor: 38.330

4.  Mutational dynamics between primary and relapse neuroblastomas.

Authors:  Alexander Schramm; Johannes Köster; Yassen Assenov; Kristina Althoff; Martin Peifer; Ellen Mahlow; Andrea Odersky; Daniela Beisser; Corinna Ernst; Anton G Henssen; Harald Stephan; Christopher Schröder; Lukas Heukamp; Anne Engesser; Yvonne Kahlert; Jessica Theissen; Barbara Hero; Frederik Roels; Janine Altmüller; Peter Nürnberg; Kathy Astrahantseff; Christian Gloeckner; Katleen De Preter; Christoph Plass; Sangkyun Lee; Holger N Lode; Kai-Oliver Henrich; Moritz Gartlgruber; Frank Speleman; Peter Schmezer; Frank Westermann; Sven Rahmann; Matthias Fischer; Angelika Eggert; Johannes H Schulte
Journal:  Nat Genet       Date:  2015-06-29       Impact factor: 38.330

5.  Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

Authors:  Yael P Mossé; Megan S Lim; Stephan D Voss; Keith Wilner; Katherine Ruffner; Julie Laliberte; Delphine Rolland; Frank M Balis; John M Maris; Brenda J Weigel; Ashish M Ingle; Charlotte Ahern; Peter C Adamson; Susan M Blaney
Journal:  Lancet Oncol       Date:  2013-04-16       Impact factor: 41.316

6.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

7.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

8.  The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts.

Authors:  O Delattre; J Zucman; T Melot; X S Garau; J M Zucker; G M Lenoir; P F Ambros; D Sheer; C Turc-Carel; T J Triche
Journal:  N Engl J Med       Date:  1994-08-04       Impact factor: 91.245

9.  Discovery and saturation analysis of cancer genes across 21 tumour types.

Authors:  Michael S Lawrence; Petar Stojanov; Craig H Mermel; James T Robinson; Levi A Garraway; Todd R Golub; Matthew Meyerson; Stacey B Gabriel; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2014-01-05       Impact factor: 49.962

10.  Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.

Authors:  Xiaotu Ma; Michael Edmonson; Donald Yergeau; Donna M Muzny; Oliver A Hampton; Michael Rusch; Guangchun Song; John Easton; Richard C Harvey; David A Wheeler; Jing Ma; HarshaVardhan Doddapaneni; Bhavin Vadodaria; Gang Wu; Panduka Nagahawatte; William L Carroll; I-Ming Chen; Julie M Gastier-Foster; Mary V Relling; Malcolm A Smith; Meenakshi Devidas; Jaime M Guidry Auvil; James R Downing; Mignon L Loh; Cheryl L Willman; Daniela S Gerhard; Charles G Mullighan; Stephen P Hunger; Jinghui Zhang
Journal:  Nat Commun       Date:  2015-03-19       Impact factor: 14.919
View more
  4 in total

1.  Ultrasensitive quantification of tumor mRNAs in extracellular vesicles with an integrated microfluidic digital analysis chip.

Authors:  Peng Zhang; Jennifer Crow; Divya Lella; Xin Zhou; Glenson Samuel; Andrew K Godwin; Yong Zeng
Journal:  Lab Chip       Date:  2018-12-04       Impact factor: 6.799

Review 2.  Genetic susceptibility to neuroblastoma.

Authors:  Vanessa P Tolbert; Grace E Coggins; John M Maris
Journal:  Curr Opin Genet Dev       Date:  2017-04-28       Impact factor: 5.578

3.  Acute lymphocytic leukemia severity and mortality hospitalizations in the United States: A population-based study.

Authors:  Saanie Sulley; Saka Abimbola; Memory Ndanga
Journal:  Int J Health Sci (Qassim)       Date:  2022 May-Jun

4.  Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.

Authors:  Jonathan M Marron; Steven G DuBois; Julia Glade Bender; AeRang Kim; Brian D Crompton; Stephanie C Meyer; Katherine A Janeway; Jennifer W Mack
Journal:  Pediatr Blood Cancer       Date:  2016-07-18       Impact factor: 3.167
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.